Connect with us

Hi, what are you looking for?

Smart Investment StepsSmart Investment Steps

Editor's Pick

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Published

Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Download the PDF here.

This post appeared first on investingnews.com

In this article:
Enter Your Information Below To Receive Latest News and Articles




    Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

    You May Also Like

    Stock

    OpenAI tops 3 million paying business users, launches new features for workplace

    OpenAI on Wednesday announced that it now has 3 million paying business users, up from the 2 million it reported in February. The San...

    June 5, 2025

    Editor's Pick

    Hempalta Provides Strategic Update Regarding Equipment Sale and FCC Agreement

    Hempalta Corp. (TSXV: HEMP) (‘Hempalta’ or the ‘Company’), a Canadian-based provider of nature-based carbon credit solutions, today issued a corporate update outlining recent developments...

    June 7, 2025

    Stock

    U.S. online stores put ‘out of stock’ signs as Nintendo Switch 2 sales hit record highs

    Nintendo sold more than 3.5 million units of its flagship Switch 2 gaming system in the four days following its launch, with online stores...

    5 days ago

    Stock

    U.S. online stores put up ‘out of stock’ signs as Nintendo Switch 2 sales hit record highs

    Nintendo sold more than 3.5 million units of its flagship Switch 2 gaming system in the four days following its launch, with online stores...

    5 days ago

    Disclaimer: smartinvestmentsteps.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 smartinvestmentsteps.com